AIDS

1. TORDOFF DM, Buskin S, Lechtenberg R, Golden MR, et al
   Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
   AIDS. 2020 Dec 10. doi: 10.1097/QAD.0000000000002783.
   

   >> Share

   
   
2. WOOD BR
   Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
   AIDS. 2020;34:2319-2320.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

3. SIM JH, Sherman JB, Stanley TL, Corey KE, et al
   Pro-inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection.
   AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0177.
   

   >> Share

   
   
4. MEHTA G, Sharma A, Arora SK
   Acquisition of additional NFkappaB binding sites in LTR of genetically evolving HIV-1 subtype C viral species in host with co-morbidities.
   AIDS Res Hum Retroviruses. 2020 Dec 14. doi: 10.1089/AID.2020.0195.
   

   >> Share

   
   
5. BORGHETTI A, Bellino S, Lombardi F, Whalen M, et al
   Risk of tumour onset in HIV+ patients on two-drug regimens: a cohort study in an Italian hospital.
   AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0087.
   

   >> Share

   
   
6. PAPASAVVAS E, Azzoni L, Pagliuzza A, Abdel-Mohsen M, et al
   Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial.
   AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0243.
   

   >> Share

   
   
7. KERRIGAN D, Murray M, Sanchez Karver T, Mantsios A, et al
   Feasibility of implementing long-acting injectable anti-retroviral therapy to treat HIV: a survey of health providers from the 13 countries participating in the ATLAS-2M trial.
   AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0208.
   

   >> Share

   
   
8. RAGONNET-CRONIN M, Benbow N, Hayford C, Poortinga K, et al
   Sorting by race/ethnicity across HIV genetic transmission networks in three major metropolitan areas in the United States.
   AIDS Res Hum Retroviruses. 2020 Dec 21. doi: 10.1089/AID.2020.0145.
   

   >> Share

   
   

   
   Am J Epidemiol

9. ARYAIE M, Sharifi H, Saber A, Nazemipour M, et al
   Longitudinal Causal Effects of Normalized Protein Catabolic Rate on All-Cause Mortality in Patients with End-Stage Renal Disease: Adjusting for Time-varying Confounders Using G-estimation Method.
   Am J Epidemiol. 2020 Dec 22. pii: 6043917. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Med

10. WANG SJ, Wade E, Towle J, Hachey T, et al
    Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates.
    Am J Med. 2020;133:1343-1349.
    

    >> Share

    
    

    
    Ann Intern Med

11. ARD KL, Walensky RP
    Payments for Preexposure Prophylaxis in the United States: Too Much for Too Few.
    Ann Intern Med. 2020;173:844-845.
    

    >> Share

    
    

    
    Clin Infect Dis

12. FLORIN TA
    Improving Risk Stratification for Children With Pneumonia: The Journey Continues.
    Clin Infect Dis. 2020;70:1058-1059.
    

    >> Share

    
    
13. BENNETT SE
    Should Women With High-risk Human Papillomavirus Infection of the Cervix Be Screened for Anal Squamous Intraepithelial Lesions?
    Clin Infect Dis. 2020;70:1129-1130.
    

    >> Share

    
    
14. MISTRANGELO M, Dal Conte I
    The Role of High-resolution Anoscopy and Random Biopsies: The Role of Infrared Coagulation vs Active Monitoring in the Treatment of High-grade Squamous Intraepithelial Lesions.
    Clin Infect Dis. 2020;70:987.
    

    >> Share

    
    
15. ROWLAND-JONES S, Yindom LM, Ferrand R
    Reply to Cevik et al.
    Clin Infect Dis. 2020;70:990-991.
    

    >> Share

    
    
16. ABU-RADDAD LJ, Chemaitelly H, Malek JA, Ahmed AA, et al
    Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
    Clin Infect Dis. 2020 Dec 14. pii: 6033728. doi: 10.1093/cid/ciaa1846.
    

    >> Share

    
    
17. STONER MCD, Westreich D, Ahern J, Edwards J, et al
    Modeling Combination Interventions to Prevent Human Immunodeficiency Virus in Adolescent Girls and Young Women in South Africa (HIV Prevention Trials Network 068).
    Clin Infect Dis. 2020 Dec 16. pii: 6039053. doi: 10.1093/cid/ciaa1598.
    

    >> Share

    
    
18. ORKIN C, Squires KE, Molina JM, Sax PE, et al
    Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferior
    Clin Infect Dis. 2020 Dec 18. pii: 6041522. doi: 10.1093.
    

    >> Share

    
    
19. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    HIV care models during the COVID-19 era.
    Clin Infect Dis. 2020 Dec 19. pii: 6041857. doi: 10.1093/cid/ciaa1864.
    

    >> Share

    
    
20. VAN DEUN A, Decroo T
    How second-line injectable drugs work.
    Clin Infect Dis. 2020 Dec 20. pii: 6042343. doi: 10.1093/cid/ciaa1874.
    

    >> Share

    
    
21. STRANIX-CHIBANDA L, Anderson PL, Kacanek D, Hosek S, et al
    Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa.
    Clin Infect Dis. 2020 Dec 20. pii: 6042339. doi: 10.1093/cid/ciaa1872.
    

    >> Share

    
    
22. DICKINSON L, Walimbwa S, Singh Y, Kaboggoza J, et al
    Infant exposure to dolutegravir through placental and breastmilk transfer: a population pharmacokinetic analysis of DolPHIN-1.
    Clin Infect Dis. 2020 Dec 21. pii: 6042568. doi: 10.1093/cid/ciaa1861.
    

    >> Share

    
    
23. IRVIN R, Gamble T, Malone J, Wang Z, et al
    HPTN 078: High Prevalence of HCV Antibodies Among Urban U.S. Men Who Have Sex with Men (MSM) Independent of HIV Status.
    Clin Infect Dis. 2020 Dec 21. pii: 6042798. doi: 10.1093/cid/ciaa1869.
    

    >> Share

    
    
24. MASYUKO SJ, Page ST, Polyak SJ, Kinuthia J, et al
    Human Immunodeficiency Virus Is Associated With Higher Levels of Systemic Inflammation Among Kenyan Adults Despite Viral Suppression.
    Clin Infect Dis. 2020 Dec 12. pii: 6031683. doi: 10.1093/cid/ciaa1650.
    

    >> Share

    
    

    
    HIV Med

25. MCLEOD A, Hutchinson SJ, Smith S, Leen C, et al
    Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.
    HIV Med. 2020 Dec 17. doi: 10.1111/hiv.13032.
    

    >> Share

    
    
26. FIGUEROA MI, Camiro-Zuniga A, Belaunzaran-Zamudio PF, Sierra Madero J, et al
    The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naive patients with HIV-infection.
    HIV Med. 2020 Dec 17. doi: 10.1111/hiv.13008.
    

    >> Share

    
    
27. PALFREEMAN A, Sullivan A, Rayment M, Waters L, et al
    British HIV Association/British Association for Sexual Health and HIV/British Infection Association adult HIV testing guidelines 2020.
    HIV Med. 2020;21 Suppl 6:1-26.
    

    >> Share

    
    
28. 
    British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.
    HIV Med. 2021;22:73.
    

    >> Share

    
    

    
    Int J Dermatol

29. TEPLYUK NP, Ruvinova PM, Varshavsky VA, Tertychnyy AS, et al
    Kaposi's sarcoma in Russian HIV-negative patients: a single-center case series.
    Int J Dermatol. 2020 Dec 15. doi: 10.1111/ijd.15368.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

30. BLAIR CS, Lake JE, Passaro RC, Chavez-Gomez S, et al
    HIV-1 Seroconversion is Not Associated with Prolonged Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
31. PEREZ-VALERO I, Llibre JM, Castagna A, Pulido F, et al
    Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
    J Acquir Immune Defic Syndr. 2020 Dec 10. doi: 10.1097/QAI.0000000000002595.
    

    >> Share

    
    
32. CHOW EPF, Ong JJ, Denham I, Fairley CK, et al
    HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
33. LEDERMAN MM
    AIDS in the Heartland- Hemophilia was the Harbinger of Things to Come.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
34. TOLENTINO A, Amaral S, Souza LS, Zeballos D, et al
    Frequency of falls and associated risk factors in people living with HIV: a systematic review with meta-analysis and meta-regression.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
35. SAMRI A, Chalouni M, Blanco J, Behrens G, et al
    Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
36. KATZ IT, Musinguzi N, Bell K, Cross A, et al
    The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era - A Multisite Cohort Study.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
37. WEISER JK, Tie Y, Beer L, Fanfair RN, et al
    Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    
38. PETOUMENOS K, Kuwanda L, Ryom L, Mocroft A, et al
    Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    

    >> Share

    
    

    
    J Immunol

39. MEZIANE O, Alexandrova Y, Olivenstein R, Dupuy FP, et al
    Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy.
    J Immunol. 2020 Dec 14. pii: jimmunol.2000916. doi: 10.4049/jimmunol.2000916.
    

    >> Share

    
    

    
    J Infect Dis

40. SUNDERMANN EE, Bondi MW, Campbell LM, Gouaux B, et al
    Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.
    J Infect Dis. 2020 Dec 15. pii: 6034152. doi: 10.1093.
    

    >> Share

    
    
41. JIANG W, Luo Z, Stephenson S, Li H, et al
    Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
    J Infect Dis. 2020 Dec 15. pii: 6035152. doi: 10.1093.
    

    >> Share

    
    
42. KIRKEGAARD-KLITBO DM, Bendtsen F, Lundgren J, de Knegt RJ, et al
    Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls.
    J Infect Dis. 2020 Dec 15. pii: 6035145. doi: 10.1093.
    

    >> Share

    
    
43. MANION M, Dulanto Chiang A, Pei L, Wong CS, et al
    Disseminated Mycobacterium marinum in HIV unmasked by Immune Reconstitution Inflammatory Syndrome.
    J Infect Dis. 2020 Dec 18. pii: 6041190. doi: 10.1093.
    

    >> Share

    
    
44. MCMAHON DK, Zheng L, Cyktor JC, Aga E, et al
    A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
    J Infect Dis. 2020 Dec 22. pii: 6043307. doi: 10.1093.
    

    >> Share

    
    
45. HEARPS AC, Angelovich TA, Trevillyan JM, Wong ME, et al
    Rosuvastatin therapy in people with HIV at intermediate cardiovascular risk does not decrease biomarkers of inflammation and immune activation.
    J Infect Dis. 2020 Dec 22. pii: 6044066. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

46. SARKAR S, Khanna P, Singh AK
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26740.
    

    >> Share

    
    
47. ANNAMALAY AA, Abbott S, Khoo SK, Hibbert J, et al
    The Impact of Cytokine Levels in Young South African Children with and without HIV-associated Acute Lower Respiratory Infections.
    J Med Virol. 2020 Dec 14. doi: 10.1002/jmv.26730.
    

    >> Share

    
    
48. CURE E, Cumhur Cure M
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25848.
    

    >> Share

    
    

    
    J Virol

49. ACHARYA A, Olwenyi OA, Thurman M, Pandey K, et al
    Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque model.
    J Virol. 2020 Dec 16. pii: JVI.01657-20. doi: 10.1128/JVI.01657.
    

    >> Share

    
    

    
    JAMA

50. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2415-2422.
    

    >> Share

    
    

    
    Lancet

51. OVERTON ET, Richmond G, Rizzardini G, Jaeger H, et al
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Lancet. 2021;396:1994-2005.
    

    >> Share

    
    
52. HOY J, McMahon J
    Is it time for injectable antiretroviral therapy for HIV?
    Lancet. 2021;396:1944-1946.
    

    >> Share

    
    
53. BURKI T
    Cheaper HIV treatment for children.
    Lancet. 2020;396:1873.
    

    >> Share

    
    

    
    Lancet Infect Dis

54. POUSTCHI H, Darvishian M, Mohammadi Z, Shayanrad A, et al
    SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Lancet Infect Dis. 2020 Dec 15. pii: S1473-3099(20)30858.
    

    >> Share

    
    
55. NKEREUWEM E, Togun T, Gomez MP, Szekely R, et al
    Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study.
    Lancet Infect Dis. 2020 Dec 11. pii: S1473-3099(20)30598.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

56. ST CYR S, Barbee L, Workowski KA, Bachmann LH, et al
    Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1911-1916.
    

    >> Share

    
    

    
    Nat Med

57. EDRIDGE AWD, Kaczorowska J, Hoste ACR, Bakker M, et al
    Seasonal coronavirus protective immunity is short-lasting.
    Nat Med. 2020;26:1691-1693.
    

    >> Share

    
    

    
    PLoS Biol

58. XU C, Fischer DK, Rankovic S, Li W, et al
    Permeability of the HIV-1 capsid to metabolites modulates viral DNA synthesis.
    PLoS Biol. 2020;18:e3001015.
    

    >> Share

    
    

    
    PLoS Med

59. HAUSER A, Kusejko K, Johnson LF, Gunthard HF, et al
    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    PLoS Med. 2020;17:e1003397.
    

    >> Share

    
    

    
    PLoS One

60. CHIBI B, Yende-Zuma N, Mashamba-Thompson TP
    Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa.
    PLoS One. 2020;15:e0243718.
    

    >> Share

    
    
61. MUDE W, Oguoma VM, Gesesew HA, Ameyaw EK, et al
    HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: Findings from a Household Survey.
    PLoS One. 2020;15:e0243969.
    

    >> Share

    
    
62. HUTSON SP, Golden A, Odoi A
    Geographic distribution of hospice, homecare, and nursing home facilities and access to end-of-life care among persons living with HIV/AIDS in Appalachia.
    PLoS One. 2020;15:e0243814.
    

    >> Share

    
    
63. 
    Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
    PLoS One. 2020;15:e0244046.
    

    >> Share

    
    
64. KOSGEI RJ, Callens S, Gichangi P, Temmerman M, et al
    Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya.
    PLoS One. 2020;15:e0243977.
    

    >> Share

    
    
65. PLYMOTH M, Sanders EJ, Van Der Elst EM, Medstrand P, et al
    Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia.
    PLoS One. 2020;15:e0244066.
    

    >> Share

    
    
66. BELAY A, Ashagrie M, Seyoum B, Alemu M, et al
    Prevalence of enteric pathogens, intestinal parasites and resistance profile of bacterial isolates among HIV infected and non-infected diarrheic patients in Dessie Town, Northeast Ethiopia.
    PLoS One. 2020;15:e0243479.
    

    >> Share

    
    
67. POURCHER V, Gourmelen J, Bureau I, Bouee S, et al
    Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    PLoS One. 2020;15:e0243529.
    

    >> Share

    
    
68. KAY AW, Thivalapill N, Skinner D, Dube GS, et al
    Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
    PLoS One. 2020;15:e0243713.
    

    >> Share

    
    
69. LOVEDAY M, Hlangu S, Furin J
    "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    PLoS One. 2020;15:e0242604.
    

    >> Share

    
    
70. LIANG S, Liu Z, Wang S, Liu J, et al
    The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    PLoS One. 2020;15:e0243650.
    

    >> Share

    
    
71. AJIBOLA G, Bennett K, Powis KM, Hughes MD, et al
    Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    PLoS One. 2020;15:e0244100.
    

    >> Share

    
    
72. TUOT S, Teo AKJ, Chhoun P, Mun P, et al
    Risk factors of HIV infection among female entertainment workers in Cambodia: Findings of a national survey.
    PLoS One. 2020;15:e0244357.
    

    >> Share

    
    
73. TOLLEY EE, Zissette S, Martinez A, Palanee-Phillips T, et al
    Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use.
    PLoS One. 2020;15:e0242881.
    

    >> Share

    
    
74. WEI Y, Silke JR, Aris P, Xia X, et al
    Coronavirus genomes carry the signatures of their habitats.
    PLoS One. 2020;15:e0244025.
    

    >> Share

    
    

    
    PLoS Pathog

75. KHAMASSI M, Xu L, Rey J, Duchemin M, et al
    The CH1alpha domain of mucosal gp41 IgA contributes to antibody specificity and antiviral functions in HIV-1 highly exposed Sero-Negative individuals.
    PLoS Pathog. 2020;16:e1009103.
    

    >> Share

    
    
76. WINANS S, Goff SP
    Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA.
    PLoS Pathog. 2020;16:e1009147.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

77. YOON JK, Holloway JR, Wells DW, Kaku M, et al
    HIV proviral DNA integration can drive T cell growth ex vivo.
    Proc Natl Acad Sci U S A. 2020 Dec 14. pii: 2013194117.
    

    >> Share

    
    

    
    Vaccine

78. DOUGLASS N, van Diepen MT, Chapman R, Galant S, et al
    Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31591.
    

    >> Share

    
    

    
    Virology

79. ZHANG Z, Perkovic M, Gu Q, Balakrishnan K, et al
    HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
    Virology. 2020;554:17-27.
    

    >> Share

    
    
80. OJWACH DBA, Madlala P, Gordon M, Ndung'u T, et al
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology. 2020;554:1-8.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share